Loading...
Designer receptor technology for the treatment of epilepsy
Epilepsy remains refractory to medical treatment in ~30% of patients despite decades of new drug development. Neurosurgery to remove or disconnect the seizure focus is often curative but frequently contraindicated by risks of irreversible impairment to brain function. Novel therapies are therefore r...
Na minha lista:
| Udgivet i: | EBioMedicine |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6558262/ https://ncbi.nlm.nih.gov/pubmed/31078519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.04.059 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|